Full text is available at the source.
The Tilapia collagen peptide mixture TY001 protects against LPS-induced inflammation, disruption of glucose metabolism, and aberrant expression of circadian clock genes in mice
Tilapia collagen peptides may reduce inflammation, blood sugar problems, and disrupted daily rhythms caused by LPS in mice
AI simplified
Abstract
TY001, a Tilapia collagen peptide mixture, significantly mitigated inflammation and improved glucose metabolism in a model of LPS-induced inflammation in mice.
- LPS injections led to increased inflammation and disrupted glucose metabolism in the mice.
- Administration of TY001 prevented elevations of inflammatory markers TNFα, IL-1β, IL-6, and IL-10 in the liver.
- TY001 improved fasting blood glucose levels and increased serum insulin levels in the presence of LPS.
- The treatment enhanced the expression of glucose transporter GLUT2 and insulin signaling components p-Akt and p-IRS-1.
- Circadian disruptions in liver clock gene expressions caused by LPS were restored with TY001 treatment.
AI simplified